Kim M. Santegoets
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma.
Journal: eLife
Published: July 20, 2026
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL.
Journal: Blood cancer journal
Published: February 16, 2025
Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity.
Journal: EBioMedicine
Published: December 12, 2022
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
Journal: Journal for immunotherapy of cancer
Published: July 24, 2020
Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
Journal: Trends in immunology
Published: July 05, 2019
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
Journal: Cancer immunology, immunotherapy : CII
Published: June 14, 2018
Interactions among myeloid regulatory cells in cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: February 21, 2018
Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia.
Journal: Clinical and experimental immunology
Published: January 24, 2017
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.
Journal: Journal of autoimmunity
Published: March 17, 2016
Impaired Porphyromonas gingivalis-Induced Tumor Necrosis Factor Production by Dendritic Cells Typifies Patients With Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 26, 2015
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia.
Journal: Blood
Published: September 19, 2014
Last Updated: 09/26/2026